Literature DB >> 10929039

Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations.

L Maeck1, D Haase, C Schoch, W Hiddemann, F Alves.   

Abstract

Using a polymerase chain reaction (PCR)-based approach, we examined the prevalence of loss of heterozygosity (LOH) and microsatellite instability (MSI) in relation to chromosomal imbalances in myelodysplastic syndrome (MDS). Two of 26 patients displayed MSI (8%), one of them at five loci. LOH was detected in six out of 26 cases (23%), predominantly involving markers IRF1 [5q31] and WT1 [11p]. Two patients displayed a corresponding chromosomal deletion by conventional cytogenetics. Supporting the mutator phenotype hypothesis, a significant coincidence of LOH, MSI and chromosome abnormalities was observed (P < 0.025). Moreover, our data suggest that LOH represents an initial rather than a secondary genetic event in MDS, promoting genetic instability in a subset of patients.

Entities:  

Mesh:

Year:  2000        PMID: 10929039     DOI: 10.1046/j.1365-2141.2000.02088.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Humans accumulate microsatellite instability with acquired loss of MLH1 protein in hematopoietic stem and progenitor cells as a function of age.

Authors:  Jonathan Kenyon; Pingfu Fu; Karen Lingas; Emily Thomas; Anshul Saurastri; Gabriela Santos Guasch; David Wald; Stanton L Gerson
Journal:  Blood       Date:  2012-06-26       Impact factor: 22.113

2.  Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying SETBP1 mutation.

Authors:  David Ullman; Erin Baumgartner; Nicholas Wnukowski; Gabe Koenig; Fady M Mikhail; Peter Pavlidakey; Deniz Peker
Journal:  Mol Clin Oncol       Date:  2017-12-08

Review 3.  New agents in myelodysplastic syndromes.

Authors:  Elias Jabbour; Francis J Giles
Journal:  Curr Hematol Malig Rep       Date:  2006-03       Impact factor: 3.952

4.  Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing.

Authors:  Jonathan Kenyon; Gabrielle Nickel-Meester; Yulan Qing; Gabriela Santos-Guasch; Ellen Drake; Shuying Sun; Xiaodong Bai; David Wald; Eric Arts; Stanton L Gerson
Journal:  Int J Stem Cell Res Ther       Date:  2016-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.